Cargando…

Editorial: Chagas disease novel drug targets and treatments

Detalles Bibliográficos
Autores principales:	Duschak, Vilma G., Paniz Mondolfi, Alberto E., Benaim, Gustavo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250960/ https://www.ncbi.nlm.nih.gov/pubmed/37305423 http://dx.doi.org/10.3389/fcimb.2023.1199715

Ejemplares similares

Editorial: Advances in the Molecular Biology of Trypanosomatid Pathogens: New Strategies Against Ancient Enemies
por: Benaim, Gustavo, et al.
Publicado: (2021)

Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target Against Trypanosoma cruzi
por: Benaim, Gustavo, et al.
Publicado: (2020)

Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease
por: Soprano, Luciana L., et al.
Publicado: (2023)

Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease
por: Soprano, Luciana L., et al.
Publicado: (2022)

Editorial: World Chagas disease day 2022
por: Palmisano, Giuseppe, et al.
Publicado: (2023)

Detangling the Crosstalk Between Ascaris, Trichuris and Gut Microbiota: What´s Next?
por: Castañeda, Sergio, et al.
Publicado: (2022)

Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease
por: Osorio-Méndez, Juan Felipe, et al.
Publicado: (2019)

Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease
por: da Costa, Kelli Monteiro, et al.
Publicado: (2021)

The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance
por: Almeida-Silva, Juliana, et al.
Publicado: (2022)

The Search for Biomarkers and Treatments in Chagas Disease: Insights From TGF-Beta Studies and Immunogenetics
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

Gut Dysbiosis in Chagas Disease. A Possible Link to the Pathogenesis
por: de Souza-Basqueira, Marcela, et al.
Publicado: (2020)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
por: Caputo, María Belén, et al.
Publicado: (2022)

Archaea Symbiont of T. cruzi Infection May Explain Heart Failure in Chagas Disease
por: Higuchi, Maria de Lourdes, et al.
Publicado: (2018)

Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models
por: Wan, Xianxiu, et al.
Publicado: (2021)

Editorial: Development of novel reagents to reverse drug resistance in bacterial pathogens
por: Li, Yasheng, et al.
Publicado: (2022)

Trypanosoma cruzi Induces Regulatory B Cell Alterations in Patients With Chronic Chagas Disease
por: Girard, Magalí C., et al.
Publicado: (2021)

Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
por: Garcia-Bustos, Victor, et al.
Publicado: (2021)

Editorial: Drug Re-purposing for the Treatment of Bacterial and Viral Infections
por: García-Contreras, Rodolfo, et al.
Publicado: (2019)

Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease
por: Quebrada Palacio, Luz P., et al.
Publicado: (2020)

Trypanosoma Species in Small Nonflying Mammals in an Area With a Single Previous Chagas Disease Case
por: Dario, Maria Augusta, et al.
Publicado: (2022)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Characterization and Follow-Up of Trypanosoma cruzi Natural Populations Refractory to Etiological Chemotherapy in Oral Chagas Disease Patients
por: Muñoz-Calderón, Arturo, et al.
Publicado: (2021)

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2023)

Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs
por: Baron, Monique Andrade, et al.
Publicado: (2022)

Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy
por: Martinez, Santiago J., et al.
Publicado: (2020)

Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects
por: Gómez, Inmaculada, et al.
Publicado: (2021)

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)

Air Pollution’s Impact on Cardiac Remodeling in an Experimental Model of Chagas Cardiomyopathy
por: Fonseca, Keila Cardoso Barbosa, et al.
Publicado: (2022)

Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Different Transcriptomic Response to T. cruzi Infection in hiPSC-Derived Cardiomyocytes From Chagas Disease Patients With and Without Chronic Cardiomyopathy
por: Oliveira, Theo G. M., et al.
Publicado: (2022)

Editorial: Emerging mosquito-borne diseases and novel biocontrol strategies
por: Deng, Sheng-Qun, et al.
Publicado: (2023)

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC
por: Pieralisi, Azul V., et al.
Publicado: (2022)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

Editorial: Drug-resistant Mycobacterium tuberculosis
por: Boshoff, Helena I. M., et al.
Publicado: (2023)

Editorial: The pathogenesis and treatment of Helicobacter pylori-induced diseases
por: Xu, Yifei, et al.
Publicado: (2023)

Editorial: From Apicomplexan Genes to Drug Discovery
por: Wunderlich, Gerhard, et al.
Publicado: (2021)

Editorial: Alternative approaches to antifungal drugs against drug-resistant fungi
por: Kovács, Renátó, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o9qn7965t44t4mmhlga1k1lfmt